Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.49 |
| ▸ | RELA | Q04206 | 4/20 | 0.45 |
| ▸ | CASP2 | P42575 | 1/20 | 0.44 |
| ▸ | NAAA | Q02083 | 1/20 | 0.42 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.42 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.42 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.42 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.42 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.41 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | RRM1 | P23921 | 1/20 | 0.40 |
| ▸ | KDM4A | O75164 | 1/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.40 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.40 |
| ▸ | DOHH | Q9BU89 | 1/20 | 0.40 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28347983 | 0.99 | SLC6A5 (0.50) | SLC6A5RELACASP2NAAAPAOX | |
| SCHEMBL30997315 | 0.99 | SLC6A5 (0.50) | SLC6A5RELACASP2NAAAPAOX | |
| SCHEMBL27490298 | 0.86 | SLC6A5 (0.46) | SLC6A5RELACASP2NAAAPAOX | |
| SCHEMBL27817058 | 0.86 | SLC6A5 (0.46) | SLC6A5RELACASP2NAAAPAOX | |
| SCHEMBL27509598 | 0.86 | SLC6A5 (0.56) | SLC6A5RELACASP2NAAAPAOX | |
| SCHEMBL27771211 | 0.86 | SLC6A5 (0.56) | SLC6A5RELACASP2NAAAPAOX | |
| SCHEMBL28817375 | 0.85 | SLC6A5 (0.47) | SLC6A5RELACASP2NAAAPAOX | |
| Spermine SCHEMBL7044349 | 0.85 | PAOX (0.45) | SLC6A5RELACASP2PAOXGNAI3 | |
| SCHEMBL1037232 | 0.82 | SLC6A5 (0.47) | SLC6A5RELACASP2NAAAPAOX | |
| SCHEMBL3394523 | 0.82 | SLC6A5 (0.47) | SLC6A5RELACASP2NAAAPAOX |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115803333-A | Trinucleotide cap analogs, their preparation and use | 生命技术公司 | 2023-03-14 | — | — | CN | claimed |
| CN-114788876-A | mRNA medicinal preparation for treating diabetes, preparation method and application thereof | 北京医院 | 2022-07-26 | — | — | CN | claimed |
| EP-1242609-A2 | NOVEL COLLOID SYNTHETIC VECTORS FOR GENE THERAPY | Novartis AG (CH) | 2002-09-25 | — | — | EP | claimed |
| WO-2001049324-A2 | NOVEL COLLOID SYNTHETIC VECTORS FOR GENE THERAPY | NOVARTIS AG (CH) | 2001-07-12 | — | — | WO | claimed |
| CN-120022384-A | Use of lipid nanoparticles in tumor treatment | 中国医学科学院基础医学研究所 | 2025-05-23 | — | — | CN | disclosed |
| CN-119968210-A | RNA for preventing or treating tuberculosis | 生物技术公司 | 2025-05-09 | — | — | CN | disclosed |
| WO-2025092908-A1 | MRNA VACCINE FOR TREATING HPV INFECTION-RELATED DISEASES | 仁景(苏州)生物科技有限公司 | 2025-05-08 | — | — | WO | disclosed |
| CN-119654139-A | RNA Lipid Nanoparticles (LNP) comprising poly oxazoline polymer and/or poly oxazine polymer | 生物技术公司 | 2025-03-18 | — | — | CN | disclosed |
| CN-119654167-A | Nucleic acid compositions comprising amphiphilic oligoethylene glycol (OEG) conjugated compounds and methods of using such compounds and compositions | 生物技术公司 | 2025-03-18 | — | — | CN | disclosed |
| CN-116783293-B | Recognition sequences in the dystrophin gene engineering with specificity meganuclease | 精密生物科学公司 | 2025-03-18 | — | — | CN | disclosed |
| WO-2025016210-A1 | NUCLEIC ACID, PHARMACEUTICAL COMPOSITION AND CONJUGATE CONTAINING NUCLEIC ACID, AND USES THEREOF | 复旦大学 | 2025-01-23 | — | — | WO | disclosed |
| CN-119278031-A | Nucleic acid compositions comprising multivalent anions, such as inorganic polyphosphates, and methods for preparing, storing, and using the same | 生物技术公司 | 2025-01-07 | — | — | CN | disclosed |
| US-20020001612-A1 | Methods of forming protein-linked lipidic microparticles, and compositions thereof | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2002-01-03 | — | — | US | disclosed |
| US-6210707-B1 | LIPID:NUCLEIC ACID COMPLEXES THAT HAVE INCREASED SHELF LIFE AND HIGH TRANSFECTION ACTIVITY IN VIVO | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2001-04-03 | — | — | US | disclosed |
| EP-1078079-A1 | METHODS OF FORMING PROTEIN-LINKED LIPIDIC MICROPARTICLES, AND COMPOSITIONS THEREOF | The Regents of the University of California (US) | 2001-02-28 | — | — | EP | disclosed |
| US-6143530-A | PLASMIDS FOR THE EXPRESSION OF HETEROLOGOUS POLYPETIDES; FOR TREATING OR PREVENTING GENETIC DISORDERS, CANCER, COAGULATION DEFECTS, VIRAL INFECTIONS AND USE IN VETERNINARY MEDICINE; ANTICARCINOGENIC AGENTS | RHONE-POULENC RORER S.A. (FR) | 2000-11-07 | — | — | US | disclosed |
| US-6071533-A | Preparation of stable formulations of lipid-nucleic acid complexes for efficient in vivo delivery | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2000-06-06 | — | — | US | disclosed |
| WO-1999058694-A1 | METHODS OF FORMING PROTEIN-LINKED LIPIDIC MICROPARTICLES, AND COMPOSITIONS THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1999-11-18 | — | — | WO | disclosed |
| EP-0956001-A1 | PREPARATION OF STABLE FORMULATIONS OF LIPID-NUCLEIC ACID COMPLEXES FOR EFFICIENT $i(IN VIVO) DELIVERY | The Regents of the University of California (US) | 1999-11-17 | — | — | EP | disclosed |
| WO-1998020857-A1 | PREPARATION OF STABLE FORMULATIONS OF LIPID-NUCLEIC ACID COMPLEXES FOR EFFICIENT IN VIVO DELIVERY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1998-05-22 | — | — | WO | disclosed |